AMBALAL SARABHAI ENTERPRISES
Back to Balance Sheet
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹7.85 Cr | ₹11 Cr | ₹12 Cr | ₹4.73 Cr | ₹5.35 Cr |
What is the latest Total Non-Current Liabilities ratio of AMBALAL SARABHAI ENTERPRISES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹7.85 Cr |
| Mar2024 | ₹11 Cr |
| Mar2023 | ₹12 Cr |
| Mar2022 | ₹4.73 Cr |
| Mar2021 | ₹5.35 Cr |
How is Total Non-Current Liabilities of AMBALAL SARABHAI ENTERPRISES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹7.85 Cr | -27.18 | |
| Mar2024 | ₹11 Cr | -9.70 | |
| Mar2023 | ₹12 Cr | 152.61 | |
| Mar2022 | ₹4.73 Cr | -11.63 | |
| Mar2021 | ₹5.35 Cr | - | |
Compare Total Non-Current Liabilities of peers of AMBALAL SARABHAI ENTERPRISES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AMBALAL SARABHAI ENTERPRISES | ₹215.2 Cr | 14.5% | 0.1% | -23.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,782.0 Cr | -1.6% | 5.7% | 7.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,125.0 Cr | -4.2% | -1.4% | 9.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,252.0 Cr | -2.8% | 5.7% | 39.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,025.0 Cr | -3.2% | 1.2% | 14.2% | Stock Analytics | |
| CIPLA | ₹102,443.0 Cr | -3.6% | -3.7% | -10.2% | Stock Analytics | |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AMBALAL SARABHAI ENTERPRISES | 14.5% |
0.1% |
-23.4% |
| SENSEX | -0.2% |
-7.2% |
3.5% |
You may also like the below Video Courses